Rationale and design of the TAXUS Libertě Post-Approval Study: Examination of patients receiving the TAXUS Liberté stent with concomitant prasugrel therapy in routine interventional cardiology practice

American Heart Journal

Volumn 163, Issue 2, 2012, Pages

  Garratt, Kirk N ^a   Lee, David P ^b   Rose, Eileen M ^c   Windle, Kellie J ^c   Liao, Hsini ^c   Nwachuku, Chuke E ^d   Winters, Kenneth J ^e   Bowman, Thomas S ^c   Dawkins, Keith D ^c  

^a LENOX HILL HOSPITAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON SCIENTIFIC CORPORATION   (United States)

^d DAIICHI SANKYO INC   (United States)

^e ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; PRASUGREL; THIENOPYRIDINE DERIVATIVE;

AGED; ARTICLE; BLEEDING; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG ELUTING STENT; HEART DEATH; HEART INFARCTION; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PATIENT ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; STENT THROMBOSIS; STROKE; TREATMENT DURATION; TREATMENT PLANNING;

EID: 84863073342     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.11.002     Document Type: Article

References (18)

1. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323 (Pubitemid 37186209)
2. G.W. Stone, S.G. Ellis, and D.A. Cox A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231 (Pubitemid 38067635)
3. J.M. Lasala, D.A. Cox, and S.J. Lewis Expanded use of the TAXUS Express stent: 2-year insights on safety from the 7500 patient ARRIVE Registry Programme Eurointervent 5 2009 67 77
4. H.K. Win, A.E. Caldera, and K. Maresh Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents JAMA 297 2007 2001 2009 (Pubitemid 46740352)
5. L. Mauri, W.H. Hsieh, and J.M. Massaro Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029 (Pubitemid 46376802)
6. R.S. Wright, J.L. Anderson, and C.D. Adams 2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline) Circulation 123 2011 2022 2060
7. S. Yusuf, F. Zhao, and S.R. Mehta Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
8. S.D. Wiviott, E. Braunwald, and C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
9. L. Mauri, D.J. Kereiakes, and S.L.T. Normand Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions Am Heart J 160 2010 1035 1041.e1
10. J.T. Brandt, C.D. Payne, and S.D. Wiviott A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation Am Heart J 153 2007 66.e9 66.e16
11. Prescribing Information, EFFIENT (prasugrel) tablets 2010 Available at: http://pi.lilly.com/us/effient.pdf Last accessed March 23, 2011
12. C.T. Chin, M.T. Roe, and K.A. Fox Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial Am Heart J 160 2010 16 22 e1
13. J.A. Jakubowski, K.J. Winters, and H. Naganuma Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile Cardiovasc Drug Rev 25 2007 357 374 (Pubitemid 350233359)
14. The GUSTO Investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
15. M.A. Turco, J.A. Ormiston, and J.J. Popma Polymer-based, paclitaxel-eluting TAXUS liberte stent in de novo lesions: the pivotal TAXUS ATLAS Trial J Am Coll Cardiol 49 2007 1676 1683 (Pubitemid 46589927)
16. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
17. G.W. Stone, S.G. Ellis, and L. Cannon Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial JAMA 294 2005 1215 1223 (Pubitemid 41352109)
18. J.M. Lasala, D.A. Cox, and D.L. Morris Two-year results of paclitaxel-eluting stents in patients with medically treated diabetes mellitus from the TAXUS ARRIVE Program Am J Cardiol 103 2009 1663 1671